Table 1 Association between the presence of GBS DNA in the placenta and the risk of neonatal unit admission, classified by clinical assessment or histopathology
Placental GBS | Univariable analysis | Multivariable analysis | ||||||
|---|---|---|---|---|---|---|---|---|
Positive n (%) | Negative n (%) | OR | 95% CI | P | OR | 95% CI | P | |
Neonatal unit admission | ||||||||
Not admitted (N = 686) | 20 (2.9) | 666 (97.1) | ||||||
All admissions (N = 239) | 16 (6.7) | 223 (93.3) | 2.4 | 1.2–4.6 | 0.009 | 2.3 | 1.4–4.5 | 0.02 |
By diagnosis | ||||||||
No sepsis (N = 60) | 2 (3.3) | 58 (96.7) | 1.1 | 0.3–4.6 | 0.85 | 1.0 | 0.2–4.4 | 0.99 |
Possible sepsis (N = 90) | 2 (2.2) | 88 (97.8) | 0.8 | 0.2–2.9 | 0.71 | 0.7 | 0.2–3.2 | 0.67 |
Probable sepsis (N = 80) | 10 (12.5) | 70 (87.5) | 4.8 | 2.2–10.3 | <0.0001 | 4.5 | 2.0–10.1 | 0.0003 |
Proven GBS sepsis (N = 3) | 2 (66.7) | 1 (33.3) | 66.6 | 7.3–963.7 | 0.003 | |||
By histopathology | ||||||||
No inflammation (N = 186) | 9 (4.8) | 177 (95.2) | 1.7 | 0.7–3.6 | 0.19 | 1.5 | 0.6–3.3 | 0.36 |
Chorioamnionitis (N = 44) | 6 (13.6) | 38 (86.4) | 5.3 | 2.0–13.4 | 0.0002 | 5.3 | 2.0–14.1 | 0.0008 |
Funisitis (N = 30) | 5 (16.7) | 25 (83.3) | 6.7 | 2.5–17.7 | 0.0001 | 5.9 | 2.0–17.3 | 0.001 |